Care teams gained significant momentum in the early days of TAVR. Now, however, they are being used to address a wide variety of cardiovascular concerns. 

According to the new proposal, the 2025 conversion factor would be $32.36, down approximately 2.8% from 2024. SCAI, MGMA and other groups have already stepped forward with warnings that these cuts could do significant damage to patient care. 

Adona Medical’s adjustable interatrial shunt can be made larger or smaller in size after implantation through the use of a custom-designed induction catheter.

Jim Melton, DO, a vascular surgeon in Oklahoma City, explains his efforts to reach patients in rural Oklahoma and Native American tribes with a mobile cardiovascular clinic program.

Patients with pulmonary hypertension are associated with increased short- and long-term risks of death following TAVR. Researchers emphasized the importance of learning as much as possible about this topic going forward. 

As one may expect, advances in TAVR and TMVR technologies are seen as key drivers of the market’s success.

According to a whistleblower, multiple Texas healthcare providers put complex heart surgeries in the hands of unqualified trainees without proper supervision. The $15M being recovered is the largest amount ever for a case of this kind. 

Value-based payments can impact cardiology practices in many ways, helping cardiologists acquire new technology and boost patient care.

Counties with no cardiologists tend to be “rural and socioeconomically disadvantaged,” researchers noted. The group called for policy reform and new technologies to help address the issue. 

The new-look PFA system from Pulse Biosciences was designed to treat AFib with a single application that lasts less than two seconds.